Movement Disorders and Mortality in Severely Mentally Ill Patients: The Curacao Extrapyramidal Syndromes Study XIV
- PMID: 35486807
- PMCID: PMC9212096
- DOI: 10.1093/schbul/sbac037
Movement Disorders and Mortality in Severely Mentally Ill Patients: The Curacao Extrapyramidal Syndromes Study XIV
Abstract
Background and hypothesis: There is a substantial gap in life expectancy between patients with severe mental illness (SMI) and the general population and it is important to understand which factors contribute to this difference. Research suggests an association between tardive dyskinesia (TD) and mortality; however, results are inconclusive. In addition, studies investigating associations between parkinsonism or akathisia and mortality are rare. We hypothesized that TD would be a risk factor for mortality in patients with SMI.
Study design: We studied a cohort of 157 patients diagnosed predominantly with schizophrenia on the former Netherlands Antilles. TD, parkinsonism, and akathisia were assessed with rating scales on eight occasions over a period of 18 years. Twenty-four years after baseline, survival status and if applicable date of death were determined. Associations between movement disorders and survival were analyzed using Cox regression. Sex, age, antipsychotics, antidepressants and benzodiazepines at each measurement occasion were tested as covariates.
Study results: Parkinsonism was a significant risk factor with an HR of 1.02 per point on the motor subscale of the Unified Parkinson's Disease Rating Scale (range 0-56). TD and akathisia were not significantly associated with mortality.
Conclusions: Parkinsonism may be an important risk factor for mortality in SMI patients. This finding calls for more follow-up and intervention studies to confirm this finding and to explore whether treatment or prevention of parkinsonism can reduce excess mortality.
Keywords: Tardive dyskinesia; akathisia; life expectancy; parkinsonism; schizophrenia; survival.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures
Similar articles
-
Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study.Aust N Z J Psychiatry. 2004 Jun;38(6):445-9. doi: 10.1080/j.1440-1614.2004.01382.x. Aust N Z J Psychiatry. 2004. PMID: 15209837
-
The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.Schizophr Res. 1997 Aug 29;26(2-3):235-42. doi: 10.1016/s0920-9964(97)00058-3. Schizophr Res. 1997. PMID: 9323356
-
Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curaçao Extrapyramidal Syndromes Study XII.J Clin Psychiatry. 2017 Mar;78(3):e279-e285. doi: 10.4088/JCP.16m11049. J Clin Psychiatry. 2017. PMID: 28199071
-
Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S49-57. doi: 10.1097/00004850-199803003-00009. Int Clin Psychopharmacol. 1998. PMID: 9690971 Review.
-
Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.Can J Psychiatry. 1994 Nov;39(9 Suppl 2):S76-80. Can J Psychiatry. 1994. PMID: 7874668 Review.
References
-
- Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res. 2011;131(1–3):101–104. - PubMed
-
- Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123–1131. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous